Profil
Martin Tolar is the founder of Alzheon, Inc., founded in 2013, serving as President, Chief Executive Officer & Director.
Former jobs include President & CEO at NormOxys, Inc. from 2009 to 2011; President, Chief Executive Officer & Director at Tafkak, Inc. in 2012; Director at BELLUS Health, Inc. in 2010; Independent Non-Executive Director at Suven Life Sciences Ltd. from 2011 to 2013; Principal at Pfizer Inc.; Chief Scientific Officer at CoMentis, Inc.; and Assistant Professor at Yale School of Medicine.
Education includes doctorates from the University of Cincinnati (Ohio) and the University of Charles.
Postes actifs de Martin Tolar
| Sociétés | Poste | Début |
|---|---|---|
| ALZHEON, INC. | Fondateur | 01/06/2013 |
Anciens postes connus de Martin Tolar
| Sociétés | Poste | Fin |
|---|---|---|
| BELLUS HEALTH | Directeur/Membre du Conseil | 27/09/2017 |
| SUVEN LIFE SCIENCES LIMITED | Directeur/Membre du Conseil | 16/01/2013 |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome sequencing and analysis solutions | Directeur Général | 01/10/2012 |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Directeur Général | - |
Formation de Martin Tolar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
BELLUS Health, Inc.
BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Health Technology |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome sequencing and analysis solutions | Commercial Services |
Alzheon, Inc.
Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
Suven Life Sciences Ltd.
Suven Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drug intermediates and chemicals | Health Technology |
University of Cincinnati (Ohio)
University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Charles
University of Charles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CoMentis, Inc.
CoMentis, Inc. Pharmaceuticals: MajorHealth Technology Focuses on developing drugs to treat various central nervous system disorders | Health Technology |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















